Atria Investments’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.89M Buy
22,950
+2,244
+11% +$180K 0.02% 783
2026
Q1
$1.57M Sell
20,706
-12,447
-38% -$972K 0.02% 817
2025
Q4
$2.48M Buy
33,153
+3,164
+11% +$236K 0.03% 632
2025
Q3
$2.21M Buy
29,989
+23,906
+393% +$1.71M 0.03% 683
2025
Q2
$430K Buy
+6,083
New +$406K 0.01% 1506

Other funds holding JIRE

Atria Investments's JIRE Position: Q2 2026 in Review

Atria Investments increased its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 11% in Q2 2026, buying an estimated $180K and bringing the position to 22,950 shares worth $1.89M. The position accounts for 0.02% of the portfolio, ranked #783.

Atria Investments first reported a position in JIRE in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.48M in Q4 2025. 350 funds tracked by Wall St. Rank hold JIRE as of Q2 2026.

  • Atria Investments held 22,950 shares of JPMorgan International Research Enhanced Equity ETF worth $1.89M as of Q2 2026.
  • Atria Investments bought 2,244 JPMorgan International Research Enhanced Equity ETF shares in Q2 2026, an estimated $180K.
  • JPMorgan International Research Enhanced Equity ETF made up 0.02% of Atria Investments's portfolio in Q2 2026, its #783 holding.
  • Atria Investments first reported a position in JPMorgan International Research Enhanced Equity ETF in Q2 2025 and has held it in 5 quarters since.
  • Atria Investments's JPMorgan International Research Enhanced Equity ETF position peaked at $2.48M in Q4 2025.
  • 350 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.